Table 1 Characteristics and medication use of outpatients and inpatients [N (%)]
Characteristics | Outpatients | Inpatients | ||||||
|---|---|---|---|---|---|---|---|---|
CHB | Cirrhosis | HCC | Total | CHB | Cirrhosis | HCC | Total | |
N | 58,857 (90.31) | 5610 (8.61) | 708 (1.09) | 65,175 (100.00) | 7224 (57.11) | 3449 (27.27) | 1976 (15.62) | 12,649 (100.00) |
Age (years)a | 35.07 ± 12.24 | 48.90 ± 12.95 | 52.62 ± 13.08 | 36.45 ± 13.02 | 34.11 ± 11.54 | 49.72 ± 12.66 | 52.02 ± 12.53 | 41.17 ± 14.53 |
Genderb | ||||||||
Male | 41,816 (71.08) | 4241 (75.61) | 603 (85.17) | 46,660 (71.62) | 5287 (73.19) | 2651 (76.86) | 1719 (86.99) | 9657 (76.35) |
Female | 17,015 (28.92) | 1368 (24.39) | 105 (14.83) | 18,488 (28.38) | 1937 (26.81) | 798 (23.14) | 257 (13.01) | 2992 (23.65) |
Payment mode | ||||||||
Self-payment | 39,481 (67.08) | 3958 (70.55) | 607 (85.73) | 44,046 (67.58) | 4756 (65.84) | 2379 (68.98) | 1393 (70.50) | 8528 (67.42) |
Medical insurance | 15,419 (26.20) | 1314 (23.42) | 75 (10.59) | 16,808 (25.79) | 2128 (29.46) | 910 (26.38) | 493 (24.95) | 3531 (27.92) |
Free medical service | 3951 (6.71) | 338 (6.02) | 26 (3.67) | 4315 (6.62) | 301 (4.17) | 130 (3.77) | 74 (3.74) | 505 (3.99) |
Othersc | 6 (0.01) | 0 (0.00) | 0 (0.00) | 6 (0.01) | 39 (0.54) | 30 (0.87) | 16 (0.81) | 85 (0.67) |
Antiviral medicine | ||||||||
Yesd | 25,525 (43.37) | 2803 (49.96) | 172 (24.29) | 28,500 (43.73) | 4036 (55.87) | 2221 (64.40) | 1031 (52.18) | 7288 (57.62) |
No | 33,332 (56.63) | 2807 (50.04) | 536 (75.71) | 36,675 (56.27) | 3188 (44.13) | 1228 (35.60) | 945 (47.82) | 5361 (42.38) |
IFN | ||||||||
Yesd | 4092 (6.95) | 44 (0.78) | 0 (0.00) | 4136 (6.35) | 1768 (24.47) | 79 (2.29) | 1 (0.05) | 1848 (14.61) |
No | 54,765 (93.05) | 5566 (99.22) | 708 (100.00) | 61,039 (93.65) | 5456 (75.53) | 3370 (97.71) | 1975 (99.95) | 10,801 (85.39) |
NAs | ||||||||
Yesd | 22,811 (38.76) | 2778 (49.52) | 172 (24.29) | 25,761 (39.53) | 2402 (33.25) | 2148 (62.28) | 1030 (52.13) | 5580 (44.11) |
No | 36,046 (61.24) | 2832 (50.48) | 536 (75.71) | 39,414 (60.47) | 4822 (66.75) | 1301 (37.72) | 946 (47.87) | 7069 (55.89) |
Hepatoprotective drugs | ||||||||
Yesd | 32,247 (54.79) | 2447 (43.62) | 207 (29.24) | 34,901 (53.55) | 6686 (92.55) | 3338 (96.78) | 1917 (97.01) | 11,941 (94.40) |
No | 26,610 (45.21) | 3163 (56.38) | 501 (70.76) | 30,274 (46.45) | 538 (7.45) | 111 (3.22) | 59 (2.99) | 708 (5.60) |
Chinese medicine | ||||||||
Yesd | 26,172 (44.47) | 3068 (54.69) | 255 (36.02) | 29,495 (45.26) | 3741 (51.79) | 2302 (66.74) | 1264 (63.97) | 7307 (57.77) |
No | 32,685 (55.53) | 2542 (45.31) | 453 (63.98) | 35,680 (54.74) | 3483 (48.21) | 1147 (33.26) | 712 (36.03) | 5342 (42.23) |
Anti-fibrotic medicine | ||||||||
Yesd | 9142 (15.53) | 3298 (58.79) | 214 (30.23) | 12,654 (19.42) | 936 (12.96) | 1895 (54.94) | 858 (43.42) | 3689 (29.16) |
No | 49,715 (84.47) | 2312 (41.21) | 494 (69.77) | 52,521 (80.58) | 6288 (87.04) | 1554 (45.06) | 1118 (56.58) | 8960 (70.84) |
Visiting timesa | 4 (2–14) | 4 (2–15) | 1 (1–3) | 4 (2–14) | 1 (1–1) | 1 (1–2) | 1 (1–1) | 1 (1–1) |